Negotiable: Paramount Recruitment: Bioinformatician - Post-Doc A thriving pharma company specialising in drug discovery & development for critical CNS conditions is seeking an exceptional Bioinformatics PhD graduate with strong analysis skills to join their select team. Cambridge, England

Competitive Salary: EMBL: Genomics Project Leader Location: Cambridge, Cambridgeshire, England

Funding Opportunity PAR-20-075 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites submission of investigator-initiated Research Program Project Grant (P01) renewal (Type 2) applications. The proposed programs should address scientific areas relevant to the NIDDK mission including diabetes, selected endocrine and metabolic diseases, obesity, digestive diseases and nutrition, and kidney, urologic and hematologic diseases, as well as new approaches to prevent, treat and cure these diseases, including clinical research. A description of NIDDK scientific program areas can be found at https://www.niddk.nih.gov/about-niddk/research-areas.

Funding Opportunity PAR-20-076 from the NIH Guide for Grants and Contracts. Reissue of PAR-17-096. The Jointly Sponsored NIH Predoctoral Training Program in the Neurosciences (JSPTPN) is an institutional program that supports broad and fundamental research training in the neurosciences. In addition to a broad education in the neurosciences, a key component will be a curriculum that provides a strong foundation in experimental design, statistical methodology and quantitative reasoning. JSPTPN programs are intended to be 2 years in duration and students may only be appointed to this training grant during the first 2 years of their graduate research training. The primary objective is to prepare students to be outstanding scientists equipped to pursue careers in neuroscience.

Notice NOT-OD-20-044 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-043 from the NIH Guide for Grants and Contracts

Notice NOT-ES-20-005 from the NIH Guide for Grants and Contracts

Notice NOT-MH-20-004 from the NIH Guide for Grants and Contracts

Notice NOT-MH-20-005 from the NIH Guide for Grants and Contracts

Notice NOT-CA-20-015 from the NIH Guide for Grants and Contracts

Notice NOT-GM-20-008 from the NIH Guide for Grants and Contracts

Notice NOT-DA-20-026 from the NIH Guide for Grants and Contracts

Notice NOT-DA-20-025 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DK-19-028 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of novel and supportive technologies for the improvement of cell replacement interventions using novel methods, biomaterials and devices for type 1 diabetes (T1D) treatment.

Funding Opportunity PAR-20-074 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the pace of translation of NCI-supported methods/assays/technologies (referred to as "assays") to the clinic. Specifically, the focus of this FOA is on the adaption and clinical validation of molecular/cellular/imaging markers (referred to as "markers" r "biomarkers") for cancer detection, diagnosis, prognosis, monitoring, and prediction of response in treatment, as well as markers for cancer control and prevention. Research applications may support the acquisition of well-annotated specimens from NCI-supported or other clinical trials or observational cohorts/consortia for the purpose of clinical validation of the assay. Research projects proposed for this FOA encourage multi-disciplinary interaction among scientific investigators, assay developers, clinicians, statisticians, and clinical laboratory staff. Clinical laboratory scientist(s) and statistical experts are highly encouraged to comprise integral parts of the application. This FOA is not intended to support early-stage development of technology or the conduct of clinical trials, but rather the adaption and validation of assays to the point where they could be integrated into clinical trials as investigational assays/tools/devices.

Notice NOT-MH-20-011 from the NIH Guide for Grants and Contracts

Competitive: Covance: Job Overview:Company Overview:If youve ever taken a medicine, received a vaccine or had blood drawn for a lab test, youve already benefited from the p Green Bay, Wisconsin (US)

£36,737 to £44,451: Wellcome Sanger Institute: Health Informatician/Data Manager Grade: 2 Salary per annum £36,737 to £44,451 Full Time or Part Time: Full Time Contract Type: Hinxton, Cambridgeshire, England

£36,737 to £44,451: Wellcome Sanger Institute: Health Informatician/Data Manager Grade: 2 Salary per annum £36,737 to £44,451 Full Time or Part Time: Full Time Contract Type: Hinxton, Cambridgeshire, England

Funding Opportunity PAR-20-069 from the NIH Guide for Grants and Contracts. The purpose of this award is to support phased transition of outstanding graduate students from groups underrepresented in the biomedical, clinical, behavioral and social sciences research enterprise from graduate work to postdoctoral research positions in Dental, Oral, and Craniofacial (DOC) research. The first phase (F99) will support the final two years of graduate research training for individuals in PhD or dual degree clinician scientist programs. Following graduation and attainment of a postdoctoral research position, the second phase (K00) will provide support for up to three years of mentored postdoctoral research.